Webinar | On demand

Illiquid Gold: Creative Dealmaking in Biotech

Cem Baydar and Paul Verdin from Evaluate are joined by Ali Pashazadeh, Max Baumann, and Mark Mayhew from Treehill Partners to discuss the latest dealmaking data, the pipeline pitfalls to avoid, and more.

Watch the webinar.

I would like to receive Evaluate industry & market reports, and the latest news from Evaluate.

Your information will be used in accordance with our Privacy notice.

Evaluate and Treehill Partners discuss the state of play and look for smart ways to get investment and deals moving as we head into 2023.

View the webinar to get insights on:

The latest IPO, M&A, and share price data
How a changing ecosystem requires innovative intervention
Optimal deal structures
The importance of good preparation and due diligence

Webinar | On demand

Illiquid Gold: Creative Dealmaking in Biotech

Watch the webinar.

Evaluate and Treehill Partners discuss the state of play and look for smart ways to get investment and deals moving as we head into 2023.

Cem Baydar, Ph.D

Chief Consulting Officer, Evaluate

Paul Verdin

VP, Head of Consulting & Analytics, Evaluate

Copyright © 2024 Evaluate, a Norstella Company